DiNuzzo Private Wealth’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03K Hold
19
﹤0.01% 457
2026
Q1
$3.72K Hold
19
﹤0.01% 454
2025
Q4
$3.3K Hold
19
﹤0.01% 477
2025
Q3
$3.45K Sell
19
-1
-5% -$177 ﹤0.01% 461
2025
Q2
$3.59K Buy
20
+1
+5% +$174 ﹤0.01% 442
2025
Q1
$3.21K Buy
19
+1
+6% +$164 ﹤0.01% 447
2024
Q4
$2.72K Hold
18
﹤0.01% 495
2024
Q3
$2.79K Buy
18
+2
+13% +$299 ﹤0.01% 498
2024
Q2
$2.19K Buy
16
+2
+14% +$274 ﹤0.01% 492
2024
Q1
$1.86K Sell
14
-1
-7% -$130 ﹤0.01% 496
2023
Q4
$2.07K Buy
+15
New +$1.97K ﹤0.01% 422

Other funds holding DGX

DiNuzzo Private Wealth's DGX Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Quest Diagnostics (DGX) position steady in Q2 2026 at 19 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

DiNuzzo Private Wealth first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • DiNuzzo Private Wealth held 19 shares of Quest Diagnostics worth $4.03K as of Q2 2026.
  • DiNuzzo Private Wealth left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #457 holding.
  • DiNuzzo Private Wealth first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.